Regulatory Affairs oversees the development and licensing of new products, regulatory compliance of existing products, provision of a medical information service and the
operation of our pharmacovigilance system.
Join our Regulatory Affairs team
Regulatory Affairs is a rewarding, intellectually stimulating and a highly regarded profession within our organisation and is an attractive career choice for those who are eager to expand their knowledge in the wide realms of the pharmaceutical world.
Some of our benefits
Flexible Working Options
With 18 locations across the globe, we offer a flexible working policy to allow you to tailor your week with your line manger and team. We offer a blend of office, hybrid, and remote roles including flexible, condensed and part time hours.
Salary and bonuses
In Northern Ireland, we rank in the top 5 companies for salaries and staff numbers, including annual bonuses and salary reviews.
Competitive Paid Leave entitlements
We offer a range of extra paid leave days on top of your annual entitlements including marriage, moving house and medical appointments. Through the one week holiday buy back scheme, employees also have flexibility around holiday allocation.
Employee Recognition Schemes
As we pride ourselves on our people, we have a variety of employee recognition schemes such as nominated awards, gift cards, long service awards and an employee referral scheme.
Training and Development
Our employees stay with us for over 8 years on average. We offer training and development opportunities, including lunchtime learning lecture programs and eLearning modules available for all staff.
Health and Wellbeing Initiatives
With a global reputation for excellence built over 50+ years, Almac works to advance human health including that of our employees. We offer private healthcare assistance, enhanced occupational sick pay, on-site physiotherapy and much more.
Employees in the spotlight
Regulatory Affairs Lead
"Almac gave me the opportunity to use my Pharmacy degree and be involved in the development of new medicines."